IL10 and ovarian carcinoma: For example, identified immunostimulatory factors (e.g. IFNG in lung cancer) are associated with a negative prognosis, whereas immunosuppressive factors (e.g. FOXP3/IL10 in ovarian cancer) are associated with a positive prognosis.